Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_assertion type Assertion NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_head.
- NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_assertion description "[Comparison of Burkitt's lymphoma-derived Akata, Mutu-I, and Daudi cells, which are representative responders and nonresponders to BCR-mediated EBV activation, respectively, indicated that three signaling pathways, phosphatidylinositol 3-kinase (PI3K), extracellular signal-regulated kinase (ERK), and p38 mitogen-activated protein kinase (MAPK), were activated in anti-Ig-treated Akata and Mutu-I cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_provenance.
- NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_assertion evidence source_evidence_literature NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_provenance.
- NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_assertion SIO_000772 14734735 NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_provenance.
- NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_assertion wasDerivedFrom befree-2016 NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_provenance.
- NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_assertion wasGeneratedBy ECO_0000203 NP428853.RA96UhSERm2vLv78GtDOl_NamA2ejZhPJxizkkPl9Zg3U130_provenance.